QT
BLCM

Quantbot Technologies’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Quantbot Technologies’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2
Closed – – 1552
2017
Q3 		$0 Sell
2
-352
-99% -$37K ﹤0.01% 1491
2017
Q2 		$41K Buy
+354
New +$43.9K ﹤0.01% 933
2015
Q4 		– Sell
-1,110
Closed -$161K – 1461
2015
Q3 		$161K Buy
+1,110
New +$204K 0.03% 598

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantbot Technologies's BLCM Position: Q4 2017 in Review

Quantbot Technologies sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2017, closing a stake of 2 shares.

Quantbot Technologies first reported a position in BLCM in Q3 2015 and held it in 3 quarters. The position peaked at $161K in Q3 2015. 91 funds tracked by Wall St. Rank hold BLCM as of Q4 2017.

  • Quantbot Technologies reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Quantbot Technologies sold 2 Bellicum Pharmaceuticals, Inc. shares in Q4 2017.
  • Quantbot Technologies first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • Quantbot Technologies's Bellicum Pharmaceuticals, Inc. position peaked at $161K in Q3 2015.
  • 91 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2017.

Based on Quantbot Technologies's 13F filing for Q4 2017, filed 12 Feb 2018.